MUMBAI, India and DUBLIN, Sept. 27, 2023 /PRNewswire/ — Cosmo Pharmaceuticals N.V. (SIX: COPN), (XETRA: C43) (“Cosmo”) and Glenmark Specialty S.A., a subsidiary of Glenmark Pharmaceuticals Ltd. (“Glenmark”), today announced the signing of distribution and license agreements for Winlevi®…